United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Jun 11, 2026 · Filed Jun 12, 2026

On Jun 11, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$549.29 for US$5.49M under a trading plan, leaving 18,876 shares. Filed Jun 12, 2026 (Form 4).

Sold
10,000 shares
Price
US$549.29 average (US$542.94 to US$551.83)
Value
US$5.49M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 11, 2026Common StockOption exercise10,000US$117.7628,876Direct
Jun 11, 2026Common StockSale46US$542.9428,830Direct
Jun 11, 2026Common StockSale154US$544.3728,676Direct
Jun 11, 2026Common StockSale442US$545.1428,234Direct
Jun 11, 2026Common StockSale134US$547.0828,100Direct
Jun 11, 2026Common StockSale2,037US$548.0226,063Direct
Jun 11, 2026Common StockSale1,974US$549.1124,089Direct
Jun 11, 2026Common StockSale3,333US$550.0420,756Direct
Jun 11, 2026Common StockSale1,560US$551.1019,196Direct
Jun 11, 2026Common StockSale320US$551.8318,876Direct

Source

View original at SEC

Related